IMR Press / EJGO / Volume 40 / Issue 5 / DOI: 10.12892/ejgo4728.2019
Open Access Review
Has the time come for therapy linked to cancer stem cells in ovarian cancer?
Show Less
1 Perinatology and Gynecology Department, Poznań University of Medical Sciences, Poznań, Poland
2 Department of Biophysics, Poznań University of Medical Sciences, Poznań, Poland
3 Department of Gynaecological Oncology, Szpital Kliniczny Przemienienia Pańskiego, Poznan University of Medical Sciences, Poznań, Poland
Eur. J. Gynaecol. Oncol. 2019 , 40(5), 697–701; https://doi.org/10.12892/ejgo4728.2019
Published: 10 October 2019
Abstract

Epithelial ovarian cancer (EOC) is the seventh most common cancer in women around the world and current therapies very rarely provide complete disease relapse. The cancer stem cell (CSC) concept has been the subject of broad recent studies. In this review the authors present basic identification methods on ovarian CSCs and current therapeutic approaches linked to this concept.

Keywords
Ovarian cancer stem cells
Ovarian cancer
Share
Back to top